WO1997025086A3 - Inhalation device - Google Patents
Inhalation device Download PDFInfo
- Publication number
- WO1997025086A3 WO1997025086A3 PCT/GB1996/003141 GB9603141W WO9725086A3 WO 1997025086 A3 WO1997025086 A3 WO 1997025086A3 GB 9603141 W GB9603141 W GB 9603141W WO 9725086 A3 WO9725086 A3 WO 9725086A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- conduit
- airflow
- baffles
- create
- inhalation device
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
- B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
- B65D83/0454—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments the whole forming a circular container with rotating parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2583/00—Containers or packages with special means for dispensing contents
- B65D2583/04—For dispensing annular, disc-shaped or spherical or like small articles or tablets
- B65D2583/0404—Indications, e.g. directions for use
- B65D2583/0409—Indications, e.g. directions for use of dates or follow-numbers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mechanical Engineering (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Manipulator (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Catching Or Destruction (AREA)
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12518396A IL125183A0 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
JP9524939A JP2000503565A (en) | 1996-01-03 | 1996-12-19 | Inhaler |
DE69618624T DE69618624T2 (en) | 1996-01-03 | 1996-12-19 | inhaler |
EP96942494A EP0883414B1 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
US09/101,102 US6065472A (en) | 1996-01-03 | 1996-12-19 | Multidose powder inhalation device |
AT96942494T ATE209053T1 (en) | 1996-01-03 | 1996-12-19 | INHALER DEVICE |
AU11633/97A AU725348B2 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
EA199800556A EA001016B1 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
APAP/P/1998/001285A AP9801285A0 (en) | 1996-01-03 | 1996-12-19 | Inhalation device. |
EA199900400A EA001237B1 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
BR9612410A BR9612410A (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
NZ324374A NZ324374A (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
PL96327616A PL327616A1 (en) | 1996-01-03 | 1996-12-19 | Inhaler |
IS4787A IS4787A (en) | 1996-01-03 | 1998-06-29 | inhalation equipment |
NO983069A NO983069L (en) | 1996-01-03 | 1998-07-02 | Inhalation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9600044.3A GB9600044D0 (en) | 1996-01-03 | 1996-01-03 | Inhalatiion device |
GB9600044.3 | 1996-12-03 | ||
GB9625134.3 | 1996-12-03 | ||
GBGB9625134.3A GB9625134D0 (en) | 1996-12-03 | 1996-12-03 | Powder inhalation device |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997025086A2 WO1997025086A2 (en) | 1997-07-17 |
WO1997025086A3 true WO1997025086A3 (en) | 1997-09-04 |
Family
ID=26308412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/003141 WO1997025086A2 (en) | 1996-01-03 | 1996-12-19 | Inhalation device |
Country Status (22)
Country | Link |
---|---|
US (1) | US6065472A (en) |
EP (2) | EP0938907B1 (en) |
JP (1) | JP2000503565A (en) |
KR (1) | KR19990077014A (en) |
CN (1) | CN1213974A (en) |
AP (1) | AP9801285A0 (en) |
AT (2) | ATE209053T1 (en) |
AU (1) | AU725348B2 (en) |
BR (1) | BR9612410A (en) |
CA (1) | CA2241880A1 (en) |
CZ (1) | CZ212598A3 (en) |
DE (2) | DE69617754T2 (en) |
EA (2) | EA001016B1 (en) |
ES (2) | ES2167987T3 (en) |
IL (1) | IL125183A0 (en) |
IS (1) | IS4787A (en) |
MX (1) | MX9805409A (en) |
NO (1) | NO983069L (en) |
NZ (1) | NZ324374A (en) |
PL (1) | PL327616A1 (en) |
TR (1) | TR199801265T2 (en) |
WO (1) | WO1997025086A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877162B2 (en) | 2000-05-10 | 2014-11-04 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
US9421166B2 (en) | 2001-12-19 | 2016-08-23 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US9554993B2 (en) | 1997-09-29 | 2017-01-31 | Novartis Ag | Pulmonary delivery particles comprising an active agent |
Families Citing this family (207)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
DK0865302T3 (en) | 1995-12-07 | 2000-10-02 | Jago Pharma Ag | Inhalator for repeated dose delivery of pharmacological dry powder |
US6006747A (en) * | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6237590B1 (en) * | 1997-09-18 | 2001-05-29 | Delsys Pharmaceutical Corporation | Dry powder delivery system apparatus |
US5954047A (en) * | 1997-10-17 | 1999-09-21 | Systemic Pulmonary Development, Ltd. | Methods and apparatus for delivering aerosolized medication |
WO1999033505A1 (en) * | 1997-12-23 | 1999-07-08 | Euro-Celtique S.A. | Particle separator for an inhaler |
NL1008031C2 (en) * | 1998-01-15 | 1999-07-21 | Pharmachemie Bv | Device for inhaling medicament. |
AU749087B2 (en) * | 1998-03-04 | 2002-06-20 | Delsys Pharmaceutical Corporation | Medicament dry powder inhaler dispensing device |
AP1342A (en) * | 1998-03-16 | 2004-12-15 | Nektar Therapeutics | Aerosolized active agent delivery. |
SE9801114D0 (en) * | 1998-03-30 | 1998-03-30 | Astra Ab | Inhalation device |
DE19831525A1 (en) * | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Media Donor |
UA73924C2 (en) * | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
GB9902493D0 (en) * | 1999-02-05 | 1999-03-24 | Glaxo Group Ltd | Inhalation device |
US6752148B1 (en) | 1999-02-10 | 2004-06-22 | Delsys Pharmaceutical Company | Medicament dry powder inhaler dispensing device |
GB9905538D0 (en) | 1999-03-10 | 1999-05-05 | Glaxo Group Ltd | A device |
ES2241611T3 (en) | 1999-06-05 | 2005-11-01 | Innovata Biomed Limited | MEDICINES SUPPLY SYSTEM. |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6606992B1 (en) * | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
EP1220700B1 (en) * | 1999-10-06 | 2003-04-09 | Eckardt, Angela | Breathing-controlled inhalation device for dry powder |
DE10027631B4 (en) * | 1999-10-06 | 2007-11-29 | Raul Goldemann | Breath-controlled dry powder inhaler and method for uniformly distributing the dry powder in air |
GB9924415D0 (en) | 1999-10-16 | 1999-12-15 | Glaxo Group Ltd | Medicament pack |
SE517806C2 (en) * | 1999-11-11 | 2002-07-16 | Microdrug Ag | Dosing device for inhaler |
US20010035184A1 (en) * | 1999-12-17 | 2001-11-01 | Carlos Schuler | Systems and methods for treating packaged powders |
US7069929B2 (en) * | 2000-02-01 | 2006-07-04 | Quadrant Technologies Limited | Dry powder inhaler |
KR100797205B1 (en) * | 2000-04-07 | 2008-01-22 | 앤디-벤티스 리미티드 | Mouthpiece for a particulate inhaler |
ATE317277T1 (en) * | 2000-04-07 | 2006-02-15 | Andi Ventis Ltd | MOUTHPIECE FOR A DEVICE FOR INHALING PARTICLES |
JP2003531123A (en) * | 2000-04-13 | 2003-10-21 | イノバータ・バイオミッド・リミテッド | Medicine |
HUP0302005A3 (en) | 2000-05-23 | 2006-07-28 | Glaxo Group Ltd | Aerosol container for formulations of salmeterol xinafoate |
GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
TWI224511B (en) * | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | De-agglomerator for breath-actuated dry powder inhaler |
PE20020066A1 (en) * | 2000-06-23 | 2002-02-23 | Norton Healthcare Ltd | PREVIOUSLY MEASURED DOSE DEPOSIT FOR DRY POWDER INHALER ACTIVATED BY BREATH |
GB0015801D0 (en) * | 2000-06-28 | 2000-08-16 | Innovata Biomed Ltd | Cover |
EP1172122A1 (en) * | 2000-07-14 | 2002-01-16 | The Technology Partnership Public Limited Company | Dry powder inhaler |
US7288390B2 (en) | 2000-08-07 | 2007-10-30 | Centocor, Inc. | Anti-dual integrin antibodies, compositions, methods and uses |
US6902734B2 (en) | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
UA81743C2 (en) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS |
AU2001283546A1 (en) | 2000-08-14 | 2002-02-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
JP2004505730A (en) * | 2000-08-15 | 2004-02-26 | ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション | Programmable multi-dose intranasal drug delivery device |
SE517227C2 (en) * | 2000-09-25 | 2002-05-14 | Microdrug Ag | Dry powder inhaler with foil cutter |
FI20002363A0 (en) * | 2000-10-27 | 2000-10-27 | Orion Yhtymae Oyj | powder inhaler |
GB0026647D0 (en) * | 2000-10-31 | 2000-12-13 | Glaxo Group Ltd | Medicament dispenser |
US7077130B2 (en) * | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
WO2002053216A2 (en) * | 2001-01-08 | 2002-07-11 | Cipla Limited | An improved device for metered administration of medicament by inhalation |
US6644309B2 (en) * | 2001-01-12 | 2003-11-11 | Becton, Dickinson And Company | Medicament respiratory delivery device and method |
US6722364B2 (en) * | 2001-01-12 | 2004-04-20 | Becton, Dickinson And Company | Medicament inhalation delivery devices and methods for using the same |
US6443152B1 (en) * | 2001-01-12 | 2002-09-03 | Becton Dickinson And Company | Medicament respiratory delivery device |
PL365736A1 (en) * | 2001-02-06 | 2005-01-10 | Innovata Biomed Limited | Bimodal dry powder formulation for inhalation |
US6766799B2 (en) * | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
FI20011317A0 (en) | 2001-06-20 | 2001-06-20 | Orion Corp | The powder inhaler |
CA2460904C (en) * | 2001-09-19 | 2011-03-22 | Advent Pharmaceuticals Pty Ltd | An inhaler for delivering metered doses of powdered medicament |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
CN100374457C (en) | 2001-11-14 | 2008-03-12 | 森托科尔公司 | Anti-IL-6 antibodies, compositions, methods and uses |
GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
AU2003215254A1 (en) | 2002-02-13 | 2003-09-04 | Immunology Laboratories, Inc. | Compositions and methods for treatment of microbial infections |
ES2300568T3 (en) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | INHALATION APPARATUS |
US7185651B2 (en) * | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
EP1545608A4 (en) | 2002-06-28 | 2006-09-13 | Centocor Inc | Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
AU2008201239B2 (en) * | 2002-10-11 | 2010-02-18 | Otsuka Pharmaceutical Co., Ltd. | Powder inhalation |
CA2694183C (en) | 2002-10-11 | 2013-06-25 | Otsuka Techno Corporation | Powder inhalator |
US6941947B2 (en) * | 2002-12-18 | 2005-09-13 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
UA89481C2 (en) | 2003-09-30 | 2010-02-10 | Центокор, Инк. | Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
WO2005041848A2 (en) * | 2003-10-27 | 2005-05-12 | Oriel Therapeutics, Inc. | Dry powder drug containment system packages with tabs, inhalers and associated methods |
WO2005040163A1 (en) | 2003-10-28 | 2005-05-06 | Dr. Reddy's Laboratories Ltd | Heterocyclic compounds that block the effects of advanced glycation end products (age) |
ITMO20040060A1 (en) * | 2004-03-18 | 2004-06-18 | Roberto Oliva | INHALER FOR POWDER PREPARATIONS |
WO2005097175A2 (en) | 2004-03-31 | 2005-10-20 | Centocor, Inc. | Human glp-1 mimetibodies, compositions, methods and uses |
WO2005102429A1 (en) * | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
MX2007001903A (en) | 2004-08-20 | 2007-08-02 | Mannkind Corp | Catalysis of diketopiperazine synthesis. |
KR101306384B1 (en) | 2004-08-23 | 2013-09-09 | 맨카인드 코포레이션 | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US7393662B2 (en) | 2004-09-03 | 2008-07-01 | Centocor, Inc. | Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
US8365725B2 (en) * | 2004-09-13 | 2013-02-05 | Oriel Therapeutics, Inc. | Dry powder inhalers that inhibit agglomeration, related devices and methods |
JP2006130143A (en) * | 2004-11-08 | 2006-05-25 | Hitachi Ltd | Inhalation administration device and medicine cartridge |
GB0427856D0 (en) | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Maniflod for use in medicament dispenser |
GB0427853D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
GB0427858D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
JO3058B1 (en) | 2005-04-29 | 2017-03-15 | Applied Molecular Evolution Inc | Anti-IL-6 Antibodies,Compositions,Methods and uses |
JP2009501006A (en) | 2005-06-30 | 2009-01-15 | セントカー・インコーポレーテツド | Anti-IL-23 antibodies, compositions, methods and uses |
US8763605B2 (en) * | 2005-07-20 | 2014-07-01 | Manta Devices, Llc | Inhalation device |
JP5465878B2 (en) | 2005-09-14 | 2014-04-09 | マンカインド コーポレイション | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
DE102005057685A1 (en) * | 2005-12-01 | 2007-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler and storage for a dry drug formulation and methods and use thereof |
AR058289A1 (en) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | COLLECTOR TO BE USED IN MEDICINAL DISPENSER |
AR058290A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | MEDICINAL DISPENSER |
HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-il-23 antibodies, compositions, methods and uses |
CN104383546B (en) | 2006-02-22 | 2021-03-02 | 曼金德公司 | Method for improving the pharmaceutical properties of microparticles comprising diketopiperazines and an active agent |
JP5188991B2 (en) * | 2006-03-03 | 2013-04-24 | エスティーシー.ユーエヌエム | Dry powder inhaler with aeroelastic distribution mechanism |
JP2010500360A (en) | 2006-08-10 | 2010-01-07 | アルボア コーポレーション | Local therapy of lower respiratory inflammatory diseases with inflammatory cytokine inhibitors |
DE102006047667B3 (en) * | 2006-09-28 | 2008-04-24 | Ing. Erich Pfeiffer Gmbh | inhalator |
WO2008051471A2 (en) * | 2006-10-19 | 2008-05-02 | Haroutunian Greg G | Flow modification device |
US9155849B2 (en) | 2006-10-19 | 2015-10-13 | G Greg Haroutunian | Flow modification device |
TW200843794A (en) | 2006-12-21 | 2008-11-16 | Centocor Inc | Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles |
US8141551B2 (en) * | 2007-02-16 | 2012-03-27 | Destal Industries, Inc. | Mouthpiece and flow rate controller for intrapulmonary delivery devices |
WO2008145348A2 (en) * | 2007-06-01 | 2008-12-04 | Boehringer Ingelheim International Gmbh | Dispensing device |
US8496002B2 (en) * | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
TW200911311A (en) * | 2007-06-15 | 2009-03-16 | Boehringer Ingelheim Int | Inhaler |
EP2230934B8 (en) | 2007-12-14 | 2012-10-24 | AeroDesigns, Inc | Delivering aerosolizable food products |
WO2009082343A1 (en) | 2007-12-20 | 2009-07-02 | Astrazeneca Ab | Dispenser and method for entraining powder in an airflow 537 |
EP2082762A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
EP2082764A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International GmbH | Inhaler |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN104689432B (en) | 2008-06-13 | 2018-07-06 | 曼金德公司 | Diskus and the system for drug conveying |
JP5479465B2 (en) | 2008-06-20 | 2014-04-23 | マンカインド コーポレイション | Interactive device and method for profiling inhalation efforts in real time |
WO2010008523A1 (en) | 2008-07-13 | 2010-01-21 | Map Pharmaceuticals, Inc. | Methods and apparatus for delivering aerosolized medication |
TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Use of ultrarapid acting insulin |
US8563697B2 (en) | 2008-08-14 | 2013-10-22 | Cephalon Australia Pty. Ltd. | Anti-IL-12/IL-23 antibodies |
UA101056C2 (en) * | 2008-10-08 | 2013-02-25 | Астразенека Аб | Inhalation device and method of dispensing medicament |
GB0818476D0 (en) * | 2008-10-09 | 2008-11-12 | Vectura Delivery Device Ltd | Inhaler |
CA2741834C (en) | 2008-10-31 | 2022-04-05 | Centocor Ortho Biotech Inc. | Fibronectin type iii domain based scaffold compositions, methods and uses |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
USD628288S1 (en) | 2009-01-22 | 2010-11-30 | Resmed Limited | Cuff for air delivery tube |
EP2396011B1 (en) | 2009-02-12 | 2016-04-13 | Janssen Biotech, Inc. | Fibronectin type iii domain based scaffold compositions, methods and uses |
PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
CA3033133C (en) | 2009-03-25 | 2021-11-09 | The Board Of Regents Of The University Of Texas System | Compositions for stimulation of mammalian innate immune resistance to pathogens |
US8985102B2 (en) | 2009-05-18 | 2015-03-24 | Adamis Pharmaceuticals Corporation | Dry powder inhalers |
EP2440184B1 (en) | 2009-06-12 | 2023-04-05 | MannKind Corporation | Diketopiperazine microparticles with defined specific surface areas |
JP2012531961A (en) | 2009-07-01 | 2012-12-13 | アストラゼネカ・アクチエボラーグ | Dispenser and method for drawing powder into an air stream |
IT1395945B1 (en) * | 2009-09-30 | 2012-11-02 | Oliva | INHALER PERFECTED FOR POWDER PREPARATIONS |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
CN102933231B (en) | 2010-02-10 | 2015-07-29 | 伊缪诺金公司 | CD20 antibody and uses thereof |
WO2011116293A2 (en) * | 2010-03-19 | 2011-09-22 | Manta Devices, Llc | Delivery device and related methods |
USD635246S1 (en) * | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
NZ603581A (en) | 2010-06-19 | 2015-05-29 | Sloan Kettering Inst Cancer | Anti-gd2 antibodies |
RU2571331C1 (en) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Systems and methods for dry powder drug delivery |
IN2013MN00222A (en) * | 2010-07-21 | 2015-05-29 | Astrazeneca Ab | |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
DE102010048316B4 (en) * | 2010-10-14 | 2016-02-11 | Primed Halberstadt Medizintechnik Gmbh | Ventilation device with a holder for speaking valves and / or heat-moisture exchanger without cannula attachment |
USD666493S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
USD666097S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666099S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666096S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666098S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666492S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
JOP20120023B1 (en) | 2011-02-04 | 2022-03-14 | Novartis Ag | Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases |
EP2688619B1 (en) * | 2011-03-21 | 2019-12-11 | Simplified Solutions Sweden AB | Inhalator for substances in powder form |
DK2694402T3 (en) | 2011-04-01 | 2017-07-03 | Mannkind Corp | BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
WO2012175735A1 (en) | 2011-06-23 | 2012-12-27 | Vib Vzw | A20 inhibitors for the treatment of respiratory viral infections |
FR2979058B1 (en) * | 2011-08-19 | 2013-08-30 | Valois Sas | INHALATION DEVICE FOR POWDER. |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents |
US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
US10105500B2 (en) * | 2012-05-09 | 2018-10-23 | Virginia Commonwealth University | Dry powder inhaler (DPI) designs for producing aerosols with high fine particle fractions |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
US9248247B2 (en) * | 2012-07-26 | 2016-02-02 | Nathaniel Gerald Portney | Capsular medication delivery and inhalation device |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
EP3278805A1 (en) | 2012-10-31 | 2018-02-07 | Galecto Biotech AB | Diagnosing pulmonary fibrosis |
CN104968656B (en) | 2012-12-19 | 2017-08-11 | 诺华股份有限公司 | autotaxin inhibitors |
TW201427681A (en) | 2013-01-07 | 2014-07-16 | Superlab Far East Ltd | A method for treating tumor by using recombinant interferon with changed spatial configuration |
US9452139B2 (en) | 2013-03-14 | 2016-09-27 | Novartis Ag | Respirable agglomerates of porous carrier particles and micronized drug |
MX2015012529A (en) | 2013-03-14 | 2016-07-05 | Novartis Ag | Deamorphization of spray-dried formulations via spray-blending. |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
KR102207859B1 (en) | 2013-03-15 | 2021-01-27 | 메모리얼 슬로안 케터링 캔서 센터 | High affinity anti-gd2 antibodies |
RU2677011C2 (en) | 2013-05-17 | 2019-01-14 | Конинклейке Филипс Н.В. | Module of substance delivery |
EP3022201A1 (en) | 2013-07-18 | 2016-05-25 | Novartis AG | Autotaxin inhibitors |
BR112016000937A8 (en) | 2013-07-18 | 2021-06-22 | Mannkind Corp | dry powder pharmaceutical formulations, method for making a dry powder formulation and use of a dry powder pharmaceutical formulation |
AU2014291711B2 (en) | 2013-07-18 | 2017-02-02 | Novartis Ag | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core |
JP2016530930A (en) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | Ventilation device and method |
DE102014005646B4 (en) * | 2014-01-30 | 2016-05-12 | Klaus-Dieter Beller | Powder inhaler and powder inhalation kit |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
EP3134398A1 (en) | 2014-04-24 | 2017-03-01 | Novartis Ag | Autotaxin inhibitors |
US10286065B2 (en) | 2014-09-19 | 2019-05-14 | Board Of Regents, The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
CA2972826C (en) | 2015-01-14 | 2023-09-12 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
WO2016149368A1 (en) | 2015-03-17 | 2016-09-22 | Memorial Sloan Kettering Cancer Center | Anti-muc16 antibodies and uses thereof |
US10179215B2 (en) | 2015-03-19 | 2019-01-15 | Altria Client Services Llc | Vaporizer for vaporizing a constituent of a plant material |
US10765821B2 (en) | 2015-03-19 | 2020-09-08 | Altria Client Services Llc | Vaporizer for vaporizing a constituent of a plant material |
US10000561B2 (en) | 2015-09-09 | 2018-06-19 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules |
RU2731644C2 (en) | 2015-09-09 | 2020-09-07 | Новартис Аг | Molecules binding to thymic stromal lymphopoietin (tslp), and methods of using such molecules |
EP3390423B1 (en) | 2015-12-18 | 2022-08-03 | Galecto Biotech AB | Polymorphic forms and process |
PL3445428T3 (en) * | 2016-04-18 | 2021-11-22 | Inspiring Pty Ltd | Spacer device for an inhaler |
US20190177421A1 (en) | 2016-07-15 | 2019-06-13 | Poseida Therapeutics, Inc. | Chimeric antigen receptors and methods for use |
EP3484927A1 (en) | 2016-07-15 | 2019-05-22 | Poseida Therapeutics, Inc. | Chimeric antigen receptors (cars) specific for muc1 and methods for their use |
CN106075677B (en) * | 2016-08-08 | 2022-06-10 | 中山市美捷时包装制品有限公司 | Actuating mechanism of dry powder inhalation device |
CA3043480A1 (en) | 2016-11-09 | 2018-05-17 | The Board Of Regents Of The University Of Texas System | Methods and compositions for adaptive immune modulation |
USD828653S1 (en) * | 2016-12-14 | 2018-09-11 | Brandon Penland | Treatment applicator |
US10569069B2 (en) | 2016-12-14 | 2020-02-25 | Combat Comb, Llc | Applicator for treatments applied to animal skin |
CN110267660A (en) | 2016-12-16 | 2019-09-20 | 德克萨斯大学系统董事会 | The inhibitor of domain protein containing Bu Luomo 4 (BRD4) |
EP3574012A1 (en) | 2017-01-27 | 2019-12-04 | Memorial Sloan Kettering Cancer Center | Bispecific her2 and cd3 binding molecules |
CA3052095A1 (en) | 2017-01-30 | 2018-08-02 | Janssen Biotech, Inc. | Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis |
MA47442A (en) | 2017-02-07 | 2019-12-18 | Janssen Biotech Inc | ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLARTHRITIS |
BR112019019107A2 (en) * | 2017-03-15 | 2020-04-22 | Csp Technologies Inc | inhaler and methods of using and producing it |
KR101992171B1 (en) * | 2017-06-27 | 2019-06-25 | 한국유나이티드제약 주식회사 | Inhaler for dry powder |
AU2018393110B2 (en) | 2017-12-20 | 2023-04-27 | Poseida Therapeutics, Inc. | VCAR compositions and methods for use |
US20190345245A1 (en) | 2018-05-11 | 2019-11-14 | Janssen Biotech, Inc. | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody |
US11389433B2 (en) | 2018-06-18 | 2022-07-19 | Board Of Regents, The University Of Texas System | BRD4 inhibitor treatment of IgE-mediated diseases |
BR112021013903A2 (en) | 2019-01-15 | 2021-09-21 | Janssen Biotech, Inc. | COMPOSITIONS AND METHODS OF ANTI-TNF ANTIBODIES FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS |
WO2020152544A1 (en) | 2019-01-23 | 2020-07-30 | Janssen Biotech, Inc. | Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis |
CN113840838A (en) | 2019-03-14 | 2021-12-24 | 詹森生物科技公司 | Methods of manufacture of compositions for the production of anti-TNF antibodies |
EP3938391A1 (en) | 2019-03-14 | 2022-01-19 | Janssen Biotech, Inc. | Methods for producing anti-tnf antibody compositions |
EP3938392A1 (en) | 2019-03-14 | 2022-01-19 | Janssen Biotech, Inc. | Methods for producing anti-tnf antibody compositions |
JP2022534020A (en) | 2019-05-23 | 2022-07-27 | ヤンセン バイオテツク,インコーポレーテツド | Methods of treating inflammatory bowel disease with combination therapy of antibodies against IL-23 and TNF-alpha |
EP3976648A1 (en) | 2019-06-03 | 2022-04-06 | Janssen Biotech, Inc. | Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis |
MX2021014882A (en) | 2019-06-03 | 2022-03-25 | Janssen Biotech Inc | Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis. |
US11458262B2 (en) | 2019-06-25 | 2022-10-04 | Altria Client Services Llc | Capsules, heat-not-burn (HNB) aerosol-generating devices, and methods of generating an aerosol |
USD916361S1 (en) | 2019-06-25 | 2021-04-13 | Altria Client Services Llc | Aerosol-generating capsule |
WO2021028752A1 (en) | 2019-08-15 | 2021-02-18 | Janssen Biotech, Inc. | Anti-tfn antibodies for treating type i diabetes |
IL297025A (en) | 2020-04-14 | 2022-12-01 | Poseida Therapeutics Inc | Compositions and methods for use in the treatment of cancer |
WO2021214588A1 (en) | 2020-04-21 | 2021-10-28 | Janssen Biotech, Inc. | Anti-tnf alpha agent for treating coronavirus infections |
WO2021214587A1 (en) | 2020-04-21 | 2021-10-28 | Janssen Biotech, Inc. | Anti-tnf alpha agent for treating viral infections |
WO2022026943A2 (en) | 2020-07-31 | 2022-02-03 | Pinetree Therapeutics, Inc. | Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infections |
US11789476B2 (en) | 2021-01-18 | 2023-10-17 | Altria Client Services Llc | Heat-not-burn (HNB) aerosol-generating devices including intra-draw heater control, and methods of controlling a heater |
US11910826B2 (en) | 2021-01-18 | 2024-02-27 | Altria Client Services Llc | Heat-not-burn (HNB) aerosol-generating devices and capsules |
WO2023279115A1 (en) | 2021-07-02 | 2023-01-05 | Henry Ford Health System | Compositions comprising endosidin 2 for reducing sars-cov-2 infection |
AU2022306144A1 (en) | 2021-07-09 | 2024-02-22 | Janssen Biotech, Inc. | Manufacturing methods for producing anti-tnf antibody compositions |
US20230042465A1 (en) | 2021-07-09 | 2023-02-09 | Janssen Biotech, Inc. | Manufacturing Methods for Producing Anti-TNF Antibody Compositions |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288277A (en) * | 1965-09-22 | 1966-11-29 | Richardson Merrell Inc | Dispensing container |
US3437236A (en) * | 1967-09-26 | 1969-04-08 | Ortho Pharma Corp | Tablet dispensing device |
US4907583A (en) * | 1986-03-07 | 1990-03-13 | Aktiebolaget Draco | Device in powder inhalators |
GB2264237A (en) * | 1992-02-05 | 1993-08-25 | Robert Edward Newell | An inhaler |
EP0558879A1 (en) * | 1992-03-04 | 1993-09-08 | Astra Aktiebolag | Disposable inhaler |
DE4208880A1 (en) * | 1992-03-19 | 1993-09-23 | Boehringer Ingelheim Kg | SEPARATOR FOR POWDER INHALATORS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
GB8614805D0 (en) | 1986-06-18 | 1986-07-23 | British American Tobacco Co | Aerosol device |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9021433D0 (en) * | 1990-10-02 | 1990-11-14 | Atomic Energy Authority Uk | Power inhaler |
US5492112A (en) * | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5896855A (en) * | 1992-12-24 | 1999-04-27 | Rhone-Poulenc Rorer Limited | Multi dose inhaler apparatus |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
-
1996
- 1996-12-19 CZ CZ982125A patent/CZ212598A3/en unknown
- 1996-12-19 US US09/101,102 patent/US6065472A/en not_active Expired - Fee Related
- 1996-12-19 WO PCT/GB1996/003141 patent/WO1997025086A2/en not_active Application Discontinuation
- 1996-12-19 CA CA002241880A patent/CA2241880A1/en not_active Abandoned
- 1996-12-19 EP EP99201271A patent/EP0938907B1/en not_active Expired - Lifetime
- 1996-12-19 TR TR1998/01265T patent/TR199801265T2/en unknown
- 1996-12-19 JP JP9524939A patent/JP2000503565A/en active Pending
- 1996-12-19 ES ES99201271T patent/ES2167987T3/en not_active Expired - Lifetime
- 1996-12-19 DE DE69617754T patent/DE69617754T2/en not_active Expired - Fee Related
- 1996-12-19 NZ NZ324374A patent/NZ324374A/en unknown
- 1996-12-19 EA EA199800556A patent/EA001016B1/en not_active IP Right Cessation
- 1996-12-19 BR BR9612410A patent/BR9612410A/en not_active Application Discontinuation
- 1996-12-19 AU AU11633/97A patent/AU725348B2/en not_active Ceased
- 1996-12-19 ES ES96942494T patent/ES2166473T3/en not_active Expired - Lifetime
- 1996-12-19 CN CN96180172A patent/CN1213974A/en active Pending
- 1996-12-19 EP EP96942494A patent/EP0883414B1/en not_active Expired - Lifetime
- 1996-12-19 AT AT96942494T patent/ATE209053T1/en not_active IP Right Cessation
- 1996-12-19 AP APAP/P/1998/001285A patent/AP9801285A0/en unknown
- 1996-12-19 IL IL12518396A patent/IL125183A0/en unknown
- 1996-12-19 AT AT99201271T patent/ATE209939T1/en not_active IP Right Cessation
- 1996-12-19 KR KR1019980705145A patent/KR19990077014A/en not_active Application Discontinuation
- 1996-12-19 PL PL96327616A patent/PL327616A1/en unknown
- 1996-12-19 EA EA199900400A patent/EA001237B1/en not_active IP Right Cessation
- 1996-12-19 DE DE69618624T patent/DE69618624T2/en not_active Expired - Fee Related
-
1998
- 1998-06-29 IS IS4787A patent/IS4787A/en unknown
- 1998-07-02 NO NO983069A patent/NO983069L/en not_active Application Discontinuation
- 1998-07-02 MX MX9805409A patent/MX9805409A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288277A (en) * | 1965-09-22 | 1966-11-29 | Richardson Merrell Inc | Dispensing container |
US3437236A (en) * | 1967-09-26 | 1969-04-08 | Ortho Pharma Corp | Tablet dispensing device |
US4907583A (en) * | 1986-03-07 | 1990-03-13 | Aktiebolaget Draco | Device in powder inhalators |
GB2264237A (en) * | 1992-02-05 | 1993-08-25 | Robert Edward Newell | An inhaler |
EP0558879A1 (en) * | 1992-03-04 | 1993-09-08 | Astra Aktiebolag | Disposable inhaler |
DE4208880A1 (en) * | 1992-03-19 | 1993-09-23 | Boehringer Ingelheim Kg | SEPARATOR FOR POWDER INHALATORS |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9554993B2 (en) | 1997-09-29 | 2017-01-31 | Novartis Ag | Pulmonary delivery particles comprising an active agent |
US8877162B2 (en) | 2000-05-10 | 2014-11-04 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
US9439862B2 (en) | 2000-05-10 | 2016-09-13 | Novartis Ag | Phospholipid-based powders for drug delivery |
US9421166B2 (en) | 2001-12-19 | 2016-08-23 | Novartis Ag | Pulmonary delivery of aminoglycoside |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997025086A3 (en) | Inhalation device | |
SE9700424D0 (en) | Powder inhales | |
GB0205572D0 (en) | Medicament delivery and packaging | |
NZ505722A (en) | Blister cracking and blister pack rotation for dry powder inhaler | |
MXPA02008403A (en) | Improvements in or relating to the delivery of oral drugs. | |
TR200002005T2 (en) | Device for inhalation of drugs used in medical practice in powder form. | |
TR200001837T2 (en) | Inhalation device | |
MXPA03010668A (en) | An inhalation device. | |
CA2334590A1 (en) | Inhalation device | |
HUP0400217A2 (en) | Dry powder inhalation system for transpulmonary administration | |
EP0839544A3 (en) | Inhalers | |
DK1220700T3 (en) | Respiratory controlled dry powder inhaler | |
WO2004112702A3 (en) | Low dose pharmaceutical powders for inhalation | |
IL136881A0 (en) | Inhalation device | |
CA2304819A1 (en) | Perforated microparticles and methods of use | |
AU1068401A (en) | Inhaler | |
WO2000074754A3 (en) | Delivery system | |
HUP0004053A2 (en) | Method of implementing halotherapy | |
WO2001087378A3 (en) | Compressed gas dry powder inhaler | |
DE60121926D1 (en) | INHALATION APPARATUS | |
SE9802380D0 (en) | Inhaler | |
TR199900235T2 (en) | Inhalation device. | |
GEP20074268B (en) | Dry powder inhalation system for transpulmonary administration | |
SE9903677L (en) | Powder inhaler for medicine | |
MX9701196A (en) | Inhaler apparatus with optimisation chamber. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96180172.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996942494 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2241880 Country of ref document: CA Ref document number: 2241880 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 324374 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998/01265 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1998/005409 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-2125 Country of ref document: CZ Ref document number: 1019980705145 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 199800556 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09101102 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-2125 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1996942494 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999/00235 Country of ref document: TR |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980705145 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-1557 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-1557 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996942494 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1998-2125 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019980705145 Country of ref document: KR |